Engineering tumor constructs to study matrix‐dependent angiogenic signaling of breast cancer cells is a research paper published in Biotechnology Progress (2022). On theSindex it has a DataRank of 0. It has been cited 4 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Alternatives Research and Development Foundation
Grant: AWD005747
Alternatives Research and Development Foundation
Grant: AWD007781
National Institute of Biomedical Imaging and Bioengineering
Grant: 1R03EB026526
National Institutes of Health
Grant: 1R03EB026526-01
Hybrid decellularized extracellular matrix hydrogel for harnessing mesenchymal stem cell pro-angiogenic potential
NIBIB NIH HHS
Grant: R03 EB026526
FWCI
0.17
Citation Percentile
0.4%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals